<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cef="http://xbrl.sec.gov/cef/2026"
  xmlns:ck0001602584="http://www.calamos.com/20260904"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ck0001602584-20260904.xsd" xlink:type="simple"/>
    <context id="C_20260904to20260904">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001602584</identifier>
        </entity>
        <period>
            <startDate>2026-09-04</startDate>
            <endDate>2026-09-04</endDate>
        </period>
    </context>
    <context id="C_20260826to20260826">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001602584</identifier>
        </entity>
        <period>
            <startDate>2026-08-26</startDate>
            <endDate>2026-08-26</endDate>
        </period>
    </context>
    <context id="C_20260826to20260826_usgaapStatementClassOfStockAxis_ck0001602584CommonSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001602584</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001602584:CommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-26</startDate>
            <endDate>2026-08-26</endDate>
        </period>
    </context>
    <context id="C_20260826to20260826_usgaapStatementClassOfStockAxis_ck0001602584MandatoryRedeemablePreferredSharesSeriesCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001602584</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001602584:MandatoryRedeemablePreferredSharesSeriesCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-26</startDate>
            <endDate>2026-08-26</endDate>
        </period>
    </context>
    <context id="C_20260826to20260826_usgaapStatementClassOfStockAxis_ck0001602584MandatoryRedeemablePreferredSharesSeriesEMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001602584</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001602584:MandatoryRedeemablePreferredSharesSeriesEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-26</startDate>
            <endDate>2026-08-26</endDate>
        </period>
    </context>
    <context id="C_20260826to20260826_usgaapStatementClassOfStockAxis_ck0001602584MandatoryRedeemablePreferredSharesSeriesGMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001602584</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001602584:MandatoryRedeemablePreferredSharesSeriesGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-26</startDate>
            <endDate>2026-08-26</endDate>
        </period>
    </context>
    <context id="C_20260826to20260826_usgaapStatementClassOfStockAxis_ck0001602584MandatoryRedeemablePreferredSharesSeriesIMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001602584</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001602584:MandatoryRedeemablePreferredSharesSeriesIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-26</startDate>
            <endDate>2026-08-26</endDate>
        </period>
    </context>
    <context id="C_20260826">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001602584</identifier>
        </entity>
        <period>
            <instant>2026-08-26</instant>
        </period>
    </context>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="SHARES">
        <measure>shares</measure>
    </unit>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Usd_per_Share">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="C_20260904to20260904"
      id="Fdei_EntityCentralIndexKey20260904030742013">0001602584</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_20260904to20260904"
      id="Fdei_AmendmentFlag20260904030745500">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_20260904to20260904"
      id="Fxbrl_20260904031401468">424B3</dei:DocumentType>
    <dei:EntityRegistrantName
      contextRef="C_20260904to20260904"
      id="Fxbrl_20260904033146551">Calamos Dynamic Convertible and Income Fund</dei:EntityRegistrantName>
    <us-gaap:SharePrice
      contextRef="C_20260826"
      decimals="2"
      id="Fxbrl_20260904040804098"
      unitRef="Usd_per_Share">24.97</us-gaap:SharePrice>
    <cef:ShareholderTransactionExpensesTableTextBlock
      contextRef="C_20260904to20260904"
      id="Fxbrl_20260904034715763">
        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif"&gt;
            
              &lt;tr style="vertical-align:bottom"&gt;
                &lt;td style="font:bold 10pt Times New Roman, Times, Serif;color:#131313;text-align:justify;border-bottom:Black 1pt solid"&gt;Shareholder Transaction Expenses&lt;/td&gt;
                &lt;td style="font-size:10pt;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="font-size:10pt;text-align:justify"&gt;&#160;&lt;/td&gt;
                &lt;td style="padding-bottom:1pt;font-size:10pt"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                &lt;td style="width:86%;font:10pt Times New Roman, Times, Serif;color:#131313;text-align:justify"&gt;Sales Load (&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;as a percentage of offering price&lt;/span&gt;)&lt;/td&gt;
                &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif;color:black"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;color:black;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;color:black;text-align:right"&gt;1.00&lt;/td&gt;
                &lt;td style="white-space:nowrap;width:1%;font:10pt Times New Roman, Times, Serif;color:black;text-align:left"&gt;%&lt;sup&gt;(1)&lt;/sup&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom"&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;color:#131313;text-align:justify"&gt;Offering Expenses Borne by the Fund (as a percentage of offering price)&lt;/td&gt;
                &lt;td style="font:10pt Symbol"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Symbol;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Symbol;text-align:right"&gt;&lt;span style="font-family:Symbol;font-size:10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
                &lt;td style="font:10pt Symbol;text-align:left"&gt;%&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;color:#131313;text-align:justify"&gt;Dividend Reinvestment Plan Fees (per sales transaction fee)(2)&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;color:black"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;color:black;text-align:left"&gt;$&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;color:black;text-align:right"&gt;15.00&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;color:black;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
            
          &lt;/table&gt;
        &lt;/div&gt;
      
        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;(1)&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&lt;/span&gt;Represents the estimated commission with respect to the Fund&#x2019;s common shares being sold in this offering. There is no guarantee that there will be any sales of the Fund&#x2019;s common shares pursuant to this prospectus supplement and the accompanying prospectus. Actual sales of the Fund&#x2019;s common shares under this prospectus supplement and the accompanying prospectus, if any, may be less than as set forth under &#x201c;Capitalization&#x201d; above. In addition, the price per share of any such sale may be greater or less than the price set forth under &#x201c;Capitalization&#x201d; above, depending on the market price of the Fund&#x2019;s common shares at the time of any such sale.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;(2)&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&lt;/span&gt;Shareholders will pay a $15.00 transaction fee plus a $0.02 per share brokerage charge if they direct Computershare Shareowner Services LLC (the &#x201c;Plan Agent&#x201d;) to sell common shares held in an account of the Fund&#x2019;s Automatic Dividend Reinvestment Plan (the &#x201c;Plan&#x201d;). In addition, each participant will pay a pro rata share of brokerage commissions incurred with respect to the Plan Agent&#x2019;s open-market purchases in connection with the reinvestment of dividends or distributions. If a participant elects to have the Plan Agent sell part or all of his or her common shares and remit the proceeds, such participant will be charged his or her pro rata share of brokerage commissions on the shares sold. See &#x201c;Dividends and Distributions on Common Shares; Automatic Dividend Reinvestment Plan&#x201d; on page 74 of the accompanying prospectus.&lt;/p&gt;
        &lt;/div&gt;
      </cef:ShareholderTransactionExpensesTableTextBlock>
    <cef:BasisOfTransactionFeesNoteTextBlock
      contextRef="C_20260904to20260904"
      id="Fxbrl_20260904035301200">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;as a percentage of offering price&lt;/span&gt;</cef:BasisOfTransactionFeesNoteTextBlock>
    <cef:SalesLoadPercent
      contextRef="C_20260904to20260904"
      decimals="4"
      id="Fxbrl_20260904035026064"
      unitRef="Pure">0.01</cef:SalesLoadPercent>
    <cef:OtherTransactionExpensesPercent
      contextRef="C_20260904to20260904"
      decimals="2"
      id="Fxbrl_20260904035031657"
      unitRef="Pure">0</cef:OtherTransactionExpensesPercent>
    <cef:DividendReinvestmentAndCashPurchaseFees
      contextRef="C_20260904to20260904"
      decimals="2"
      id="Fxbrl_20260904035039804"
      unitRef="USD">15</cef:DividendReinvestmentAndCashPurchaseFees>
    <cef:AnnualExpensesTableTextBlock
      contextRef="C_20260904to20260904"
      id="Fxbrl_20260904034734604">
        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif"&gt;
            
              &lt;tr style="vertical-align:bottom"&gt;
                &lt;td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;color:#131313;text-align:left"&gt;Annual Expenses&lt;/td&gt;
                &lt;td style="font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;Percentage of Average Net&lt;br/&gt;Assets Attributable to&lt;br/&gt;Common Shareholders&lt;/td&gt;
                &lt;td style="font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;width:76%;color:#131313;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt;color:#131313"&gt;Management Fee&lt;sup&gt;(3)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;width:20%;text-align:right"&gt;1.45&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;%&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom"&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;color:#131313;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt;color:#131313"&gt;Interest Payments on Borrowed Funds&lt;sup&gt;(4)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;1.30&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;color:#131313;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt;color:#131313"&gt;Preferred Stock Dividend Payments&lt;sup&gt;(5)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0.57&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom"&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;color:#131313;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt;color:#131313"&gt;Other Expenses&lt;sup&gt;(6)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0.08&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt;color:#010101"&gt;Total &lt;/span&gt;&lt;span style="color:#131313"&gt;Annual Expenses&lt;/span&gt;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;3.40&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
              &lt;/tr&gt;
            
          &lt;/table&gt;
        &lt;/div&gt;
      
        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;(3)&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&lt;/span&gt;The Fund pays Calamos an annual management fee, payable monthly in arrears, for its investment management services in an amount equal to 1.00% of the Fund&#x2019;s average weekly managed assets. In accordance with the requirements of the Commission, the table above shows the Fund&#x2019;s management fee as a percentage of average net assets attributable to common shareholders. By showing the management fee as a percentage of net assets, the management fee is not expressed as a percentage of all of the assets the Fund intends to invest. For purposes of the table, the management fee has been converted to 1.45% of the Fund&#x2019;s average weekly net assets as of August 26, 2026 by dividing the total dollar amount of the management fee by the Fund&#x2019;s average weekly net assets (managed assets less outstanding leverage).&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;(4)&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&lt;/span&gt;Reflects interest expense paid on $48 million in average borrowings under the Fund&#x2019;s Amended and Restated Liquidity Agreement with State Street Bank and Trust Company, plus $148 million in additional average structural leverage related to certain securities lending programs, as described in the accompanying prospectus under &#x201c;Leverage.&#x201d;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;(5)&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&lt;/span&gt;Reflects estimated dividend expense on $91.8 million aggregate liquidation preference of mandatory redeemable preferred shares (&#x201c;MRP Shares&#x201d; or &#x201c;MRPS&#x201d;) outstanding. See &#x201c;Prospectus Summary- Use of Leverage by the Fund&#x201d; and &#x201c;Leverage&#x201d; in the accompanying prospectus for additional information.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;(6)&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;&#x201c;Other Expenses&#x201d; are based on estimated amounts for the Fund&#x2019;s current fiscal year.&lt;/span&gt;&lt;/p&gt;
        &lt;/div&gt;
      </cef:AnnualExpensesTableTextBlock>
    <cef:ManagementFeesPercent
      contextRef="C_20260904to20260904"
      decimals="4"
      id="Fxbrl_20260904035043315"
      unitRef="Pure">0.0145</cef:ManagementFeesPercent>
    <cef:InterestExpensesOnBorrowingsPercent
      contextRef="C_20260904to20260904"
      decimals="4"
      id="Fxbrl_20260904035047191"
      unitRef="Pure">0.013</cef:InterestExpensesOnBorrowingsPercent>
    <cef:DividendExpenseOnPreferredSharesPercent
      contextRef="C_20260904to20260904"
      decimals="4"
      id="Fxbrl_20260904035051074"
      unitRef="Pure">0.0057</cef:DividendExpenseOnPreferredSharesPercent>
    <cef:OtherAnnualExpensesPercent
      contextRef="C_20260904to20260904"
      decimals="4"
      id="Fxbrl_20260904035055602"
      unitRef="Pure">0.0008</cef:OtherAnnualExpensesPercent>
    <cef:TotalAnnualExpensesPercent
      contextRef="C_20260904to20260904"
      decimals="4"
      id="Fxbrl_20260904035100809"
      unitRef="Pure">0.034</cef:TotalAnnualExpensesPercent>
    <cef:ExpenseExampleTableTextBlock
      contextRef="C_20260904to20260904"
      id="Fxbrl_20260904034830364">
        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;Example:&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;The following example illustrates the expenses that common shareholders would pay on a $1,000 investment in common shares, assuming (1) net annual expenses of 3.40% of net assets attributable to common shareholders; (2) a 5% annual gross return; and &lt;/span&gt;&lt;span style="color:#131313"&gt;(3) all distributions are reinvested at net asset value:&lt;/span&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif"&gt;
            
              &lt;tr style="vertical-align:bottom"&gt;
                &lt;td style="font-size:10pt;text-align:justify"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;1 Year&lt;/td&gt;
                &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;3 Years&lt;/td&gt;
                &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;5 Years&lt;/td&gt;
                &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;10 Years&lt;/td&gt;
                &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                &lt;td style="width:44%;font:10pt Times New Roman, Times, Serif;text-align:justify"&gt;Total Expenses Paid by Common Shareholders(7)&lt;/td&gt;
                &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;44&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;113&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;185&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;375&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
            
          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;The example should not be considered a representation of future expenses. Actual expenses may be greater or less than those assumed. Moreover, our actual rate of return may be greater or less than the hypothetical 5% return shown in the example.&lt;/strong&gt;&lt;/p&gt;
        &lt;/div&gt;
      
          &lt;div&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;(7)&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&lt;/span&gt;The example includes sales load and estimated offering costs.&lt;/p&gt;
          &lt;/div&gt;
        </cef:ExpenseExampleTableTextBlock>
    <cef:ExpenseExampleYear01
      contextRef="C_20260904to20260904"
      decimals="0"
      id="Fxbrl_20260904034912258"
      unitRef="USD">44</cef:ExpenseExampleYear01>
    <cef:ExpenseExampleYears1to3
      contextRef="C_20260904to20260904"
      decimals="0"
      id="Fxbrl_20260904034915673"
      unitRef="USD">113</cef:ExpenseExampleYears1to3>
    <cef:ExpenseExampleYears1to5
      contextRef="C_20260904to20260904"
      decimals="0"
      id="Fxbrl_20260904034921192"
      unitRef="USD">185</cef:ExpenseExampleYears1to5>
    <cef:ExpenseExampleYears1to10
      contextRef="C_20260904to20260904"
      decimals="0"
      id="Fxbrl_20260904034925441"
      unitRef="USD">375</cef:ExpenseExampleYears1to10>
    <cef:OtherExpensesNoteTextBlock
      contextRef="C_20260904to20260904"
      id="Fxbrl_20260904035713145">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;&#x201c;Other Expenses&#x201d; are based on estimated amounts for the Fund&#x2019;s current fiscal year.&lt;/span&gt;</cef:OtherExpensesNoteTextBlock>
    <cef:PurposeOfFeeTableNoteTextBlock
      contextRef="C_20260904to20260904"
      id="Fxbrl_20260904035644186">
          &lt;div style="font-size:10pt;font-family:Times New Roman"&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The purpose of the table and the example above is to help investors understand the fees and expenses that they, as common shareholders, would bear directly or indirectly. For additional information with respect to our expenses, see &#x201c;Management of the Fund&#x201d; on page 87 of the accompanying prospectus.&lt;/p&gt;
          &lt;/div&gt;
        </cef:PurposeOfFeeTableNoteTextBlock>
    <cef:InvestmentObjectivesAndPracticesTextBlock
      contextRef="C_20260904to20260904"
      id="Fxbrl_20260904044037751">
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Fund is a diversified, closed-end management investment company. We commenced operations in March 2015 following our initial public offering. As of August 26, 2026, we had $991.6 million of total managed assets, including &lt;span style="color:#343434"&gt;$&lt;/span&gt;91.8 million of outstanding mandatory redeemable preferred shares (&#x201c;MRP Shares&#x201d; or &#x201c;MRPS&#x201d;). As of August 26, 2026, the Fund had utilized $214.8 million of the $370 million available under the Amended and Restated Liquidity Agreement (the &#x201c;SSB Agreement&#x201d;) with State Street Bank and Trust Company (&#x201c;SSB&#x201d; or &#x201c;State Street&#x201d;) ($114.3 million of borrowings outstanding, and $100.5 million in structural leverage consisting of collateral received from SSB in connection with securities on loan), representing 21.7% of the Fund&#x2019;s managed assets as of that date, and had $91.8 million of MRP Shares outstanding, representing 9.2% of the Fund&#x2019;s managed assets. Combined, the borrowings under the SSB Agreement and the outstanding MRP Shares represented 30.9% of the Fund&#x2019;s managed assets. Structural leverage refers to borrowings under the liquidity agreement in respect of which the Fund&#x2019;s interest payments are reduced or eliminated by the Fund&#x2019;s securities lending activities. See &#x201c;Leverage.&#x201d; Our fiscal year ends on October 31. Our investment objective is to provide total return through a combination of capital appreciation and current income.&lt;/p&gt;
      </cef:InvestmentObjectivesAndPracticesTextBlock>
    <cef:OutstandingSecuritiesTableTextBlock
      contextRef="C_20260826to20260826"
      id="Fxbrl_20260904043345169">
        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The following table provides information about our outstanding securities as of August 26, 2026:&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif"&gt;
            
              &lt;tr style="vertical-align:bottom"&gt;
                &lt;td style="font:bold 10pt Times New Roman, Times, Serif;text-align:left;border-bottom:Black 1pt solid"&gt;Title of Class&lt;/td&gt;
                &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;Amount&lt;br/&gt;Authorized&lt;/td&gt;
                &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center;border-bottom:Black 0.5pt solid"&gt;&lt;strong&gt;Amount Held by &lt;span style="color:#010101"&gt;the&lt;/span&gt;&lt;br/&gt;Fund for &lt;span style="color:#010101"&gt;its &lt;/span&gt;Account&lt;/strong&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;Amount&lt;br/&gt;Outstanding&lt;/td&gt;
                &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                &lt;td style="width:43%;font:10pt Times New Roman, Times, Serif;text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Common Shares&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:15%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;Unlimited&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:15%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:15%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;28,619,559.59&lt;/td&gt;
                &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom"&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;MRPS-Series C&lt;/span&gt;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;860,000&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;860,000&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;MRPS-Series E&lt;/span&gt;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;850,000&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;850,000&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom"&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;MRPS-Series G&lt;/span&gt;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;840,000&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;840,000&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;MRPS Series I&lt;/span&gt;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;1,120,000&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;1,120,000&lt;/td&gt;
                &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
            
          &lt;/table&gt;
        &lt;/div&gt;
      </cef:OutstandingSecuritiesTableTextBlock>
    <cef:OutstandingSecurityTitleTextBlock
      contextRef="C_20260826to20260826_usgaapStatementClassOfStockAxis_ck0001602584CommonSharesMember"
      id="Fxbrl_20260904043449385">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Common Shares&lt;/span&gt;</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityHeldShares
      contextRef="C_20260826to20260826_usgaapStatementClassOfStockAxis_ck0001602584CommonSharesMember"
      decimals="0"
      id="Fxbrl_20260904043652857"
      unitRef="SHARES">0</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="C_20260826to20260826_usgaapStatementClassOfStockAxis_ck0001602584CommonSharesMember"
      decimals="2"
      id="Fxbrl_20260904043726841"
      unitRef="SHARES">28619559.59</cef:OutstandingSecurityNotHeldShares>
    <cef:OutstandingSecurityTitleTextBlock
      contextRef="C_20260826to20260826_usgaapStatementClassOfStockAxis_ck0001602584MandatoryRedeemablePreferredSharesSeriesCMember"
      id="Fxbrl_20260904043504494">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;MRPS-Series C&lt;/span&gt;</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityAuthorizedShares
      contextRef="C_20260826to20260826_usgaapStatementClassOfStockAxis_ck0001602584MandatoryRedeemablePreferredSharesSeriesCMember"
      decimals="0"
      id="Fxbrl_20260904043623784"
      unitRef="SHARES">860000</cef:OutstandingSecurityAuthorizedShares>
    <cef:OutstandingSecurityHeldShares
      contextRef="C_20260826to20260826_usgaapStatementClassOfStockAxis_ck0001602584MandatoryRedeemablePreferredSharesSeriesCMember"
      decimals="0"
      id="Fxbrl_20260904043707585"
      unitRef="SHARES">0</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="C_20260826to20260826_usgaapStatementClassOfStockAxis_ck0001602584MandatoryRedeemablePreferredSharesSeriesCMember"
      decimals="0"
      id="Fxbrl_20260904043750305"
      unitRef="SHARES">860000</cef:OutstandingSecurityNotHeldShares>
    <cef:OutstandingSecurityTitleTextBlock
      contextRef="C_20260826to20260826_usgaapStatementClassOfStockAxis_ck0001602584MandatoryRedeemablePreferredSharesSeriesEMember"
      id="Fxbrl_20260904043517038">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;MRPS-Series E&lt;/span&gt;</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityAuthorizedShares
      contextRef="C_20260826to20260826_usgaapStatementClassOfStockAxis_ck0001602584MandatoryRedeemablePreferredSharesSeriesEMember"
      decimals="0"
      id="Fxbrl_20260904043631368"
      unitRef="SHARES">850000</cef:OutstandingSecurityAuthorizedShares>
    <cef:OutstandingSecurityHeldShares
      contextRef="C_20260826to20260826_usgaapStatementClassOfStockAxis_ck0001602584MandatoryRedeemablePreferredSharesSeriesEMember"
      decimals="0"
      id="Fxbrl_20260904043710480"
      unitRef="SHARES">0</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="C_20260826to20260826_usgaapStatementClassOfStockAxis_ck0001602584MandatoryRedeemablePreferredSharesSeriesEMember"
      decimals="0"
      id="Fxbrl_20260904043755024"
      unitRef="SHARES">850000</cef:OutstandingSecurityNotHeldShares>
    <cef:OutstandingSecurityTitleTextBlock
      contextRef="C_20260826to20260826_usgaapStatementClassOfStockAxis_ck0001602584MandatoryRedeemablePreferredSharesSeriesGMember"
      id="Fxbrl_20260904043530240">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;MRPS-Series G&lt;/span&gt;</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityAuthorizedShares
      contextRef="C_20260826to20260826_usgaapStatementClassOfStockAxis_ck0001602584MandatoryRedeemablePreferredSharesSeriesGMember"
      decimals="0"
      id="Fxbrl_20260904043634815"
      unitRef="SHARES">840000</cef:OutstandingSecurityAuthorizedShares>
    <cef:OutstandingSecurityHeldShares
      contextRef="C_20260826to20260826_usgaapStatementClassOfStockAxis_ck0001602584MandatoryRedeemablePreferredSharesSeriesGMember"
      decimals="0"
      id="Fxbrl_20260904043713521"
      unitRef="SHARES">0</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="C_20260826to20260826_usgaapStatementClassOfStockAxis_ck0001602584MandatoryRedeemablePreferredSharesSeriesGMember"
      decimals="0"
      id="Fxbrl_20260904043809960"
      unitRef="SHARES">840000</cef:OutstandingSecurityNotHeldShares>
    <cef:OutstandingSecurityTitleTextBlock
      contextRef="C_20260826to20260826_usgaapStatementClassOfStockAxis_ck0001602584MandatoryRedeemablePreferredSharesSeriesIMember"
      id="Fxbrl_20260904043542473">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;MRPS Series I&lt;/span&gt;</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityAuthorizedShares
      contextRef="C_20260826to20260826_usgaapStatementClassOfStockAxis_ck0001602584MandatoryRedeemablePreferredSharesSeriesIMember"
      decimals="0"
      id="Fxbrl_20260904043638631"
      unitRef="SHARES">1120000</cef:OutstandingSecurityAuthorizedShares>
    <cef:OutstandingSecurityHeldShares
      contextRef="C_20260826to20260826_usgaapStatementClassOfStockAxis_ck0001602584MandatoryRedeemablePreferredSharesSeriesIMember"
      decimals="0"
      id="Fxbrl_20260904043716577"
      unitRef="SHARES">0</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="C_20260826to20260826_usgaapStatementClassOfStockAxis_ck0001602584MandatoryRedeemablePreferredSharesSeriesIMember"
      decimals="0"
      id="Fxbrl_20260904043813680"
      unitRef="SHARES">1120000</cef:OutstandingSecurityNotHeldShares>
    <cef:EffectsOfLeverageTextBlock
      contextRef="C_20260904to20260904"
      id="Fxbrl_20260904041012290">
        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt;color:#111111"&gt;&lt;i&gt;The &lt;/i&gt;&lt;/span&gt;&lt;i&gt;&lt;span style="color:#1f1f1f"&gt;section &lt;/span&gt;&lt;span style="color:#111111"&gt;titled &#x201c;Effects of Leverage&#x201d; beginning on page 59 of the &lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;Prospectus &lt;/span&gt;&lt;span style="color:#111111"&gt;is deleted in its &lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;entirety and &lt;/span&gt;&lt;span style="color:#111111"&gt;replaced with the following:&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt;color:#111111"&gt;The SSB Agreement provides for credit availability for the Fund, &lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;such &lt;/span&gt;&lt;span style="color:#111111"&gt;that it may borrow up to $&lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;370 &lt;/span&gt;&lt;span style="color:#111111"&gt;million. As of August 26, 2026&lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;, &lt;/span&gt;&lt;span style="color:#111111"&gt;the Fund had utilized &lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;$214.8 &lt;/span&gt;&lt;span style="color:#111111"&gt;million of the &lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;$370 &lt;/span&gt;&lt;span style="color:#111111"&gt;million available under the SSB Agreement ($&lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;114.3 &lt;/span&gt;&lt;span style="color:#111111"&gt;million in borrowings outstanding, and &lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;$100.5 &lt;/span&gt;&lt;span style="color:#111111"&gt;million in &lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;structural &lt;/span&gt;&lt;span style="color:#111111"&gt;leverage consisting of collateral received from SSB in connection &lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;with &lt;/span&gt;&lt;span style="color:#111111"&gt;securities on loan), representing &lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;21.7&lt;/span&gt;&lt;span style="color:#111111"&gt;% of the Fund&#x2019;s managed assets as of that date, &lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;and &lt;/span&gt;&lt;span style="color:#111111"&gt;had $&lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;91.8 &lt;/span&gt;&lt;span style="color:#111111"&gt;million of MRP Shares outstanding, representing &lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;9.2&lt;/span&gt;&lt;span style="color:#111111"&gt;% of the Fund&#x2019;s managed assets. &lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;Combined, &lt;/span&gt;&lt;span style="color:#111111"&gt;the borrowings under the SSB &lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;Agreement and &lt;/span&gt;&lt;span style="color:#111111"&gt;the outstanding MRP Shares represented &lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;30.9&lt;/span&gt;&lt;span style="color:#111111"&gt;% of the Fund&#x2019;s managed &lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;assets. &lt;/span&gt;&lt;span style="color:#111111"&gt;Interest on the SSB Agreement is charged on the drawn amount &lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;at &lt;/span&gt;&lt;span style="color:#111111"&gt;the rate of the Overnight Bank Financing Rate (&#x201c;OBFR&#x201d;) plus &lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;0.52&lt;/span&gt;&lt;span style="color:#111111"&gt;%, payable monthly in &lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;arrears. &lt;/span&gt;&lt;span style="color:#111111"&gt;Interest on overdue amounts or interest on the drawn amount paid during &lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;an event &lt;/span&gt;&lt;span style="color:#111111"&gt;of default will be &lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;charged at &lt;/span&gt;&lt;span style="color:#111111"&gt;OBFR plus &lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;2.52&lt;/span&gt;&lt;span style="color:#111111"&gt;%. These rates represent floating &lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;rates &lt;/span&gt;&lt;span style="color:#111111"&gt;of interest that may &lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;change &lt;/span&gt;&lt;span style="color:#111111"&gt;over time. The SSB &lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;Agreement &lt;/span&gt;&lt;span style="color:#111111"&gt;has a commitment fee of &lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;0.10&lt;/span&gt;&lt;span style="color:#111111"&gt;% of any undrawn &lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;amount. As &lt;/span&gt;&lt;span style="color:#111111"&gt;of August 26, 2026, the interest rate charged under the SSB &lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;Agreement &lt;/span&gt;&lt;span style="color:#111111"&gt;was &lt;/span&gt;&lt;span style="color:#1f1f1f"&gt;4.22&lt;/span&gt;&lt;span style="color:#111111"&gt;%.&lt;/span&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Fund&#x2019;s MRP Shareholders are entitled to receive monthly cash dividends, at a currently effective dividend rate per annum for each series of MRP Shares as follows (subject to adjustment as described above in &#x201c;Mandatory Redeemable Preferred Shares&#x201d;): 4.24% for Series C MRP Shares, 2.68% for Series E MRP Shares, 6.24% for Series G MRP Shares, and 6.03% for Series I MRP Shares.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;To cover the interest expense on the borrowings under the SSB Agreement (including &#x201c;net income&#x201d; payments made with respect to borrowings offset by collateral for securities on loan) and the dividend payments associated with the MRP Shares, based on rates in effect on August 26, 2026, the Fund&#x2019;s portfolio would need to experience an annual return of 1.26% (before giving effect to expenses associated with senior securities).&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;Leverage is a speculative technique that could adversely affect the returns to common shareholders. Leverage can cause the Fund to lose money and can magnify the effect of any losses. To the extent the income or capital appreciation derived from securities purchased with funds received from leverage exceeds the cost of leverage, the Fund&#x2019;s return will be greater than if leverage had not been used. Conversely, if the income or capital appreciation from the securities purchased with such funds is not sufficient to cover the cost of leverage or if the Fund incurs capital losses, the return of the Fund will be less than if leverage had not been used, and therefore the amount available for distribution to common shareholders as dividends and other distributions will be reduced or potentially eliminated.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Fund will pay, and common shareholders will effectively bear, any costs and expenses relating to any borrowings and to the issuance and ongoing maintenance of preferred shares, including the MRP Shares, or debt securities. Such costs and expenses include the higher management fee resulting from the use of any such leverage, offering and/or issuance costs, and interest and/or dividend expense and ongoing maintenance.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;Certain types of borrowings may result in the Fund being subject to covenants in credit agreements, including those relating to asset coverage, borrowing base and portfolio composition requirements and additional covenants that may affect the Fund&#x2019;s ability to pay dividends and distributions on common shares in certain instances. The Fund may also be required to pledge its assets to the lenders in connection with certain types of borrowings. The Fund may be subject to certain restrictions on investments imposed by guidelines of and covenants with rating agencies for the preferred shares or short-term debt instruments issued by the Fund. These guidelines and covenants may impose asset coverage or portfolio composition requirements that are more stringent than those imposed by the 1940 Act.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;Because Calamos&#x2019; investment management fee is a percentage of the Fund&#x2019;s managed assets, Calamos&#x2019; fee will be higher if the Fund is leveraged and Calamos will have an incentive to be more aggressive and leverage the Fund. Consequently, the Fund and Calamos may have differing interests in determining whether to leverage the Fund&#x2019;s assets. Any additional use of leverage by the Fund effected through new, additional or increased credit facilities or the issuance of preferred shares would require approval by the Board of Trustees of the Fund.&lt;/p&gt;
        &lt;/div&gt;
      
        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
          
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The following table illustrates the hypothetical effect on the return to a holder of the Fund&#x2019;s common shares of the leverage obtained by us (and utilized on August 26, 2026). The purpose of this table is to assist you in understanding the effects of leverage. As the table shows, leverage generally increases the return to common shareholders when portfolio return is positive and greater than the cost of leverage and decreases the return when the portfolio return is negative or less than the cost of leverage. The figures appearing in the table are hypothetical and actual returns may be greater or less than those appearing in the table.&lt;/p&gt;
          
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
          
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif"&gt;
                
                  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                    &lt;td style="width:40%;font:10pt Times New Roman, Times, Serif;text-align:justify"&gt;Assumed Portfolio Return (Net of Expenses)&lt;/td&gt;
                    &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:8%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(10.00&lt;/td&gt;
                    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:8%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(5.00&lt;/td&gt;
                    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:8%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0.00&lt;/td&gt;
                    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
                    &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:8%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;5.00&lt;/td&gt;
                    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
                    &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:8%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.00&lt;/td&gt;
                    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom"&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;Corresponding Common Share Return&lt;sup&gt;(l)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(16.30&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(9.07&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(1.83&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;color:#1f1f1f"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;color:#1f1f1f;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;color:#1f1f1f;text-align:right"&gt;5.41&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;color:#1f1f1f;text-align:left"&gt;%&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;color:#1f1f1f"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;color:#1f1f1f;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;color:#1f1f1f;text-align:right"&gt;12.64&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;color:#1f1f1f;text-align:left"&gt;%&lt;/td&gt;
                  &lt;/tr&gt;
                
              &lt;/table&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;(1) Includes interest expense on the borrowings under the SSB Agreement, accrued at interest rates in effect on August 26, 2026 of 4.22%, and dividend expense on the MRP Shares.&lt;/p&gt;
            &lt;/div&gt;
          
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;For further information about leveraging, see &#x201c;Risk Factors - Fund Risks - Leverage Risk.&#x201d;&lt;/p&gt;
        &lt;/div&gt;
      </cef:EffectsOfLeverageTextBlock>
    <cef:EffectsOfLeveragePurposeTextBlock
      contextRef="C_20260904to20260904"
      id="Fxbrl_20260904041050953">
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The following table illustrates the hypothetical effect on the return to a holder of the Fund&#x2019;s common shares of the leverage obtained by us (and utilized on August 26, 2026). The purpose of this table is to assist you in understanding the effects of leverage. As the table shows, leverage generally increases the return to common shareholders when portfolio return is positive and greater than the cost of leverage and decreases the return when the portfolio return is negative or less than the cost of leverage. The figures appearing in the table are hypothetical and actual returns may be greater or less than those appearing in the table.&lt;/p&gt;
          </cef:EffectsOfLeveragePurposeTextBlock>
    <cef:EffectsOfLeverageTableTextBlock
      contextRef="C_20260904to20260904"
      id="Fxbrl_20260904041645503">
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif"&gt;
                
                  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                    &lt;td style="width:40%;font:10pt Times New Roman, Times, Serif;text-align:justify"&gt;Assumed Portfolio Return (Net of Expenses)&lt;/td&gt;
                    &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:8%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(10.00&lt;/td&gt;
                    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:8%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(5.00&lt;/td&gt;
                    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:8%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0.00&lt;/td&gt;
                    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
                    &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:8%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;5.00&lt;/td&gt;
                    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
                    &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:8%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.00&lt;/td&gt;
                    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="vertical-align:bottom"&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;Corresponding Common Share Return&lt;sup&gt;(l)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(16.30&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(9.07&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(1.83&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;color:#1f1f1f"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;color:#1f1f1f;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;color:#1f1f1f;text-align:right"&gt;5.41&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;color:#1f1f1f;text-align:left"&gt;%&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;color:#1f1f1f"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;color:#1f1f1f;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;color:#1f1f1f;text-align:right"&gt;12.64&lt;/td&gt;
                    &lt;td style="font:10pt Times New Roman, Times, Serif;color:#1f1f1f;text-align:left"&gt;%&lt;/td&gt;
                  &lt;/tr&gt;
                
              &lt;/table&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;(1) Includes interest expense on the borrowings under the SSB Agreement, accrued at interest rates in effect on August 26, 2026 of 4.22%, and dividend expense on the MRP Shares.&lt;/p&gt;
            &lt;/div&gt;
          </cef:EffectsOfLeverageTableTextBlock>
    <cef:ReturnAtMinusTenPercent
      contextRef="C_20260904to20260904"
      decimals="4"
      id="Fxbrl_20260904041153306"
      unitRef="Pure">-0.163</cef:ReturnAtMinusTenPercent>
    <cef:ReturnAtMinusFivePercent
      contextRef="C_20260904to20260904"
      decimals="4"
      id="Fxbrl_20260904041157009"
      unitRef="Pure">-0.0907</cef:ReturnAtMinusFivePercent>
    <cef:ReturnAtZeroPercent
      contextRef="C_20260904to20260904"
      decimals="4"
      id="Fxbrl_20260904041200528"
      unitRef="Pure">-0.0183</cef:ReturnAtZeroPercent>
    <cef:ReturnAtPlusFivePercent
      contextRef="C_20260904to20260904"
      decimals="4"
      id="Fxbrl_20260904041206433"
      unitRef="Pure">0.0541</cef:ReturnAtPlusFivePercent>
    <cef:ReturnAtPlusTenPercent
      contextRef="C_20260904to20260904"
      decimals="4"
      id="Fxbrl_20260904041209886"
      unitRef="Pure">0.1264</cef:ReturnAtPlusTenPercent>
    <cef:AnnualInterestRatePercent
      contextRef="C_20260826to20260826"
      decimals="4"
      id="Fxbrl_20260904041431497"
      unitRef="Pure">0.0422</cef:AnnualInterestRatePercent>
    <cef:CapitalStockTableTextBlock
      contextRef="C_20260904to20260904"
      id="Fxbrl_20260904044321695">
    &lt;div&gt;
      &lt;p style="font:bold 10pt Times New Roman, Times, Serif;margin:0pt 0;text-transform:uppercase;text-align:center"&gt;&lt;strong&gt;DESCRIPTION OF SECURITIES&lt;/strong&gt;&lt;/p&gt;
      &lt;p style="font:bold 10pt Times New Roman, Times, Serif;margin:0pt 0;text-transform:uppercase;text-align:center"&gt;&#160;&lt;/p&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;The Fund is authorized to issue an unlimited number of common shares, without par value. The Fund is also authorized to issue preferred shares and debt securities. As of August 26, 2026, the Fund had 28,619,559.59 common shares outstanding and MRP Shares outstanding in the following amounts: 860,000 Series C MRP Shares, 850,000 Series E MRP Shares, 840,000 Series G MRP Shares, and 1,120,000 of Series I MRP Shares. As of such date, the Fund had not issued any debt securities. Subject to the restrictions under the 1940 Act, the Board of Trustees may, from time to time, establish additional series or classes of Fund shares and set forth the designations, preferences, conversion or other rights, voting powers, restrictions, limitations as to dividends, qualifications or terms or conditions of redemption of such shares and pursuant to such classification or reclassification to increase or decrease the number of authorized shares of any existing class or series but the Board may not change any outstanding shares in a manner materially adverse to such shareholders. The Board of Trustees, without shareholder approval but subject to the &lt;/span&gt;&lt;span style="color:#131313"&gt;governing documents of the Fund and the MRP Shares, is authorized to amend the Agreement and Declaration of Trust and By-Laws to reflect the terms of any such class or series.&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;As of August 26, 2026, the Fund had total leverage of approximately $306.5 million representing approximately 30.9% of the Fund&#x2019;s managed assets as of that date. The Fund will pay, and common shareholders will effectively bear, any costs and expenses relating to any borrowings by the Fund, including the financial leverage described above, as well as any additional leverage incurred as a result of this offering. Such costs and expenses include the higher management fee resulting from the use of any such leverage, offering and/or issuance costs, and interest and/or dividend expense and ongoing maintenance. Borrowings under the SSB Agreement are secured by assets of the Fund that are held with the Fund&#x2019;s custodian in a separate account. Interest on the SSB Agreement is charged on the drawn amount at the rate of OBFR plus 0.52%, payable monthly in arrears. Interest on overdue amounts or interest on the drawn amount paid during an event of default will be charged at OBFR plus 2.52%. The SSB Agreement has a commitment fee of 0.10% of any undrawn amount. As of August 26, 2026, the interest rate charged under the SSB Agreement was 4.22%. Prior to January 1, 2022, the reference rate used by the SSB Agreement was Overnight LIBOR.&lt;/p&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;strong&gt;II.&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&#x202f;&lt;/strong&gt;&lt;/span&gt;&lt;strong&gt;Further Revisions to Disclosure&lt;/strong&gt;&lt;/p&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;All disclosure in the Fund&#x2019;s Prospectus, SAI and Prospectus Supplement not specifically referenced above is hereby amended to the extent necessary to conform to the information provided in this supplement.&lt;/p&gt;
    &lt;/div&gt;
  </cef:CapitalStockTableTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fxbrl_20260904034912258"
          xlink:label="Fxbrl_20260904034912258"
          xlink:type="locator"/>
        <link:footnote id="FN20260904041932566" xlink:label="FN20260904041932566" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The example includes sales load and estimated offering costs.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260904034912258"
          xlink:to="FN20260904041932566"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260904034915673"
          xlink:label="Fxbrl_20260904034915673"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260904034915673"
          xlink:to="FN20260904041932566"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260904034921192"
          xlink:label="Fxbrl_20260904034921192"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260904034921192"
          xlink:to="FN20260904041932566"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260904034925441"
          xlink:label="Fxbrl_20260904034925441"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260904034925441"
          xlink:to="FN20260904041932566"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260904035026064"
          xlink:label="Fxbrl_20260904035026064"
          xlink:type="locator"/>
        <link:footnote id="FN20260904042026402" xlink:label="FN20260904042026402" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the estimated commission with respect to the Fund&#x2019;s common shares being sold in this offering. There is no guarantee that there will be any sales of the Fund&#x2019;s common shares pursuant to this prospectus supplement and the accompanying prospectus. Actual sales of the Fund&#x2019;s common shares under this prospectus supplement and the accompanying prospectus, if any, may be less than as set forth under &#x201c;Capitalization&#x201d; above. In addition, the price per share of any such sale may be greater or less than the price set forth under &#x201c;Capitalization&#x201d; above, depending on the market price of the Fund&#x2019;s common shares at the time of any such sale.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260904035026064"
          xlink:to="FN20260904042026402"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260904035039804"
          xlink:label="Fxbrl_20260904035039804"
          xlink:type="locator"/>
        <link:footnote id="FN20260904042040250" xlink:label="FN20260904042040250" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Shareholders will pay a $15.00 transaction fee plus a $0.02 per share brokerage charge if they direct Computershare Shareowner Services LLC (the &#x201c;Plan Agent&#x201d;) to sell common shares held in an account of the Fund&#x2019;s Automatic Dividend Reinvestment Plan (the &#x201c;Plan&#x201d;). In addition, each participant will pay a pro rata share of brokerage commissions incurred with respect to the Plan Agent&#x2019;s open-market purchases in connection with the reinvestment of dividends or distributions. If a participant elects to have the Plan Agent sell part or all of his or her common shares and remit the proceeds, such participant will be charged his or her pro rata share of brokerage commissions on the shares sold. See &#x201c;Dividends and Distributions on Common Shares; Automatic Dividend Reinvestment Plan&#x201d; on page 74 of the accompanying prospectus.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260904035039804"
          xlink:to="FN20260904042040250"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260904035043315"
          xlink:label="Fxbrl_20260904035043315"
          xlink:type="locator"/>
        <link:footnote id="FN20260904042242305" xlink:label="FN20260904042242305" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Fund pays Calamos an annual management fee, payable monthly in arrears, for its investment management services in an amount equal to 1.00% of the Fund&#x2019;s average weekly managed assets. In accordance with the requirements of the Commission, the table above shows the Fund&#x2019;s management fee as a percentage of average net assets attributable to common shareholders. By showing the management fee as a percentage of net assets, the management fee is not expressed as a percentage of all of the assets the Fund intends to invest. For purposes of the table, the management fee has been converted to 1.45% of the Fund&#x2019;s average weekly net assets as of August 26, 2026 by dividing the total dollar amount of the management fee by the Fund&#x2019;s average weekly net assets (managed assets less outstanding leverage).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260904035043315"
          xlink:to="FN20260904042242305"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260904035047191"
          xlink:label="Fxbrl_20260904035047191"
          xlink:type="locator"/>
        <link:footnote id="FN20260904043058602" xlink:label="FN20260904043058602" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Reflects interest expense paid on $48 million in average borrowings under the Fund&#x2019;s Amended and Restated Liquidity Agreement with State Street Bank and Trust Company, plus $148 million in additional average structural leverage related to certain securities lending programs, as described in the accompanying prospectus under &#x201c;Leverage.&#x201d;</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260904035047191"
          xlink:to="FN20260904043058602"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260904035051074"
          xlink:label="Fxbrl_20260904035051074"
          xlink:type="locator"/>
        <link:footnote id="FN20260904043212421" xlink:label="FN20260904043212421" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Reflects estimated dividend expense on $91.8 million aggregate liquidation preference of mandatory redeemable preferred shares (&#x201c;MRP Shares&#x201d; or &#x201c;MRPS&#x201d;) outstanding. See &#x201c;Prospectus Summary- Use of Leverage by the Fund&#x201d; and &#x201c;Leverage&#x201d; in the accompanying prospectus for additional information.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260904035051074"
          xlink:to="FN20260904043212421"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260904035055602"
          xlink:label="Fxbrl_20260904035055602"
          xlink:type="locator"/>
        <link:footnote id="FN20260904043228218" xlink:label="FN20260904043228218" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">&#x201c;Other Expenses&#x201d; are based on estimated amounts for the Fund&#x2019;s current fiscal year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260904035055602"
          xlink:to="FN20260904043228218"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260904041153306"
          xlink:label="Fxbrl_20260904041153306"
          xlink:type="locator"/>
        <link:footnote id="FN20260904041734183" xlink:label="FN20260904041734183" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes interest expense on the borrowings under the SSB Agreement, accrued at interest rates in effect on August 26, 2026 of 4.22%, and dividend expense on the MRP Shares.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260904041153306"
          xlink:to="FN20260904041734183"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260904041157009"
          xlink:label="Fxbrl_20260904041157009"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260904041157009"
          xlink:to="FN20260904041734183"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260904041200528"
          xlink:label="Fxbrl_20260904041200528"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260904041200528"
          xlink:to="FN20260904041734183"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260904041206433"
          xlink:label="Fxbrl_20260904041206433"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260904041206433"
          xlink:to="FN20260904041734183"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260904041209886"
          xlink:label="Fxbrl_20260904041209886"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260904041209886"
          xlink:to="FN20260904041734183"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
